World

WHO boss says vaccine IP waiver not a property ‘snatch’

With lives on the line, Tedros Adhanom Ghebreyesus calls for profits, patents to take a back seat

Updated 5 years ago · Published on 22 Jul 2021 9:30AM

WHO boss says vaccine IP waiver not a property ‘snatch’
WHO Director-General Tedros Adhanom Ghebreyesus said vaccine makers should be offered incentives in return for temporarily waiving intellectual property rights. – AFP pic, July 22, 2021

GENEVA – The World Health Organisation (WHO) yesterday sought to reassure pharmaceutical companies that a proposal to suspend patent rights on Covid-19 vaccines was not a bid to “snatch” their intellectual property(IP) rights.

With more than four million dead and the toll likely to reach much higher, WHO Director-General Tedros Adhanom Ghebreyesus said vaccine makers should be offered incentives in return for temporarily waiving IP rights.

“Of course, we can’t snatch your property,” Tedros said via video link from Tokyo at the start of a meeting with the World Trade Organisation, pharmaceutical companies and global financial institutions.

“With so many lives on the line, profits and patents must come second,” he said, without giving any details on the proposed financial incentives.

Waiving intellectual property rights would help meet the 11 billion doses of vaccine the WHO says are needed to protect 70% of people in every country by mid-2022.

This is the second meeting in Geneva to try to bridge differences on how to increase supply of jabs and cut the vaccine inequity that sees rich countries eyeing booster shots while health workers in poor countries go without.

Of the 1.1 billion doses produced globally in June, “only 1.4% went to Africans, who account for 17% of the global population”, WTO Director-General Ngozi Okonjo-Iweal said in her opening speech.

“Only 0.24% went to people in low-income countries. And both shares declined even further in the first half of July,” she said.

In addition to the suspension of patents, barriers to the trade in vaccine ingredients must be removed and laboratories agree to transfer their technology, Tedros said. – AFP, July 22, 2021

Related News

Malaysia / 2y

Current health ailments not related to AstraZeneca vaccine, says Noor Hisham

Malaysia / 2y

Govt aware of AstraZeneca vaccine side effects when it was deployed, says Noor Hisham

World / 2y

AstraZeneca Covid-19 vaccine to be withdrawn globally

World / 2y

AstraZeneca admits Covishield can cause blood clots, low platelet count

Malaysia / 2y

8.5 million doses of Covid-19 vaccine worth RM505 mil expired since June 1: PAC

Health / 3y

WHO, US health authorities tracking new Covid-19 variant

Spotlight

Malaysia

Haze: Schools in Johor, Melaka, and Negeri Sembilan to close tomorrow

Malaysia

Tun Mahathir’s health improves, but not ready to leave hospital

Malaysia

LPT3 row puts Kelantan’s infrastructure priorities under scrutiny

Malaysia

Terengganu royal family member sues two banks over RM1.99m missing from savings

Malaysia

Irene Sofiya murder probe referred to Johor prosecutors for review

Malaysia

Teacher denies negligence charges over fatal school SUV crash in Kota Bharu

Malaysia

Sulaiman Md Ali opts out of Melaka polls, will not defend Lendu

You may be interested

World

Five Malaysians held in Tokyo over RM3.1m cocaine haul hidden in shoes

World

Indonesia rules out national disaster status for forest fires despite regional haze

World

Iran says US response on Hormuz Strait reopening proposal falls short

World

North Korea test-fires tactical ballistic missile amid rising regional tensions

World

Fresh magnitude-6 earthquake strikes Panama after deadly tremor

World

Houthi attacks hit Riyadh, Dammam airports as Saudi Arabia faces mounting security threat

World

IMF warns AI sell-off; Soaring bond yields could trigger global market turmoil